News and press

Filter by:

25th April 2014

Quality

In line with the announcement of our annual Report and Accounts, we have today published our Quality Account.

25th April 2014

Strong financial performance as we transition to new brand

GSTS Pathology announces strong financial performance for 2013 and transitions to new brand - Viapath.

23rd April 2014

Evaluation of the validity of Hb A2 and mean corpuscular haemoglobin action values in antenatal screening for beta thalassaemia carriers in England

National antenatal screening of all pregnant women in England is carried out using standards and guidelines produced by the National Health Service Sickle Cell and Thalassaemia Screening Programme.

Dr Yvonne Daniel , Ronwyn Cartwright, Kristian Rennie, Allison Streetly, Jo Howard

15th April 2014

Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2

David Taylor, Alaghband-Zadeh, Cross GF, Omar S, le Roux CW, Vincent RP

7th April 2014

New name, same commitment to transform pathology services

On 1st May 2014 GSTS Pathology and KingsPath become Viapath.

21st March 2014

Large scale investment in our systems

We have today announced that we have awarded a seven year contract to Cerner UK to deliver and host our PathNet laboratory information management system for our flagship services with Guy’s and St Thomas’ NHS Foundation Trust.

17th March 2014

Steroids excreted in urine by neonates with 21-hydroxylase deficiency. 3. Characterization, using GC-MS and GC-MS/MS, of androstanes and androstenes.

Sofia Christakoudi , David A. Cowan

10th March 2014

Analyzing Chromosomes (Basics: from Background to Bench)

7th March 2014

Predicting refeeding syndrome: Insulin-like growth factor 1 (IGF1) as a diagnostic biochemical marker for clinical practice

Goyale A, Ashley SL, David Taylor, Elnenaei MO, Alaghband-Zadeh J, le Roux CW, Vincent RP

12th February 2014

The Creation of a Complete Biogenic Amines Service

Dr Colin Stone